Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AB1 | P08238 | 3/20 | 0.46 |
| ▸ | KDM2B | Q8NHM5 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4976976 | 1.00 | HSP90AB1 (0.46) | HSP90AB1KDM2BACHEMAPTTRPM8 | |
| SCHEMBL4976818 | 0.92 | HSP90AB1 (0.42) | HSP90AB1KDM2BMAPTALDH1A1HRH3 | |
| SCHEMBL4976823 | 0.92 | HSP90AB1 (0.42) | HSP90AB1KDM2BMAPTALDH1A1HRH3 | |
| SCHEMBL4981982 | 0.90 | ALDH1A1 (0.46) | HSP90AB1KDM2BACHEMAPTALDH1A1 | |
| SCHEMBL4981967 | 0.90 | ALDH1A1 (0.46) | HSP90AB1KDM2BACHEMAPTALDH1A1 | |
| SCHEMBL4980613 | 0.90 | L3MBTL1 (0.42) | HSP90AB1KDM2BMAPTTRPM8L3MBTL1 | |
| SCHEMBL4980622 | 0.90 | L3MBTL1 (0.42) | HSP90AB1KDM2BMAPTTRPM8L3MBTL1 | |
| SCHEMBL4976717 | 0.88 | KDM4E (0.52) | HSP90AB1ACHEL3MBTL1ALDH1A1TDP1 | |
| SCHEMBL4976734 | 0.88 | KDM4E (0.52) | HSP90AB1ACHEL3MBTL1ALDH1A1TDP1 | |
| SCHEMBL4978465 | 0.88 | L3MBTL1 (0.55) | HSP90AB1MAPTL3MBTL1ALDH1A1HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080051387-A1 | TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES | NEUROGEN CORPORATION | 2008-02-28 | — | — | US | disclosed |
| US-20080051387-A1 | TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES | NEUROGEN CORPORATION | 2008-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080051387-A1 | TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES | HRH3, HRH4, HRH2 | HSP90AB1 2652/4885KDM2B 1937/4885ACHE 2948/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.